Navigation Links
Hepatitis B accounts for 40 percent of 'missing' Asian women

In a groundbreaking, sure-to-be-controversial new study, Emily Oster (a graduate student in economics at Harvard University) argues that excess female mortality, such as infanticide, may not be the only cause of uncommonly high male to female ratios in many Asian countries. It has long been observed that the relative number of males is higher in certain Asian countries than in the West, where it is close to unity. A number of authors have suggested that this imbalance reflects neglect of female children and poor conditions for women and, as a result, have argued that as many as 100 million women are "missing."

However, in the forthcoming issue of the Journal of Political Economy, Oster proposes an explanation for some of the observed over-representation of males: the hepatitis B virus. She presents new evidence, consistent with existing scientific literature, that carriers of the hepatitis B virus are 1.5 times more likely to have a male child. This evidence includes both cross-country analyses and natural experimentation based on recent vaccination campaigns. In addition, hepatitis B is common in many Asian countries, particularly China, where some 10 to 15 percent of the population is infected.

Using data on viral prevalence by country as well as estimates of the effect of hepatitis on birth sex, Oster concludes that hepatitis B can account for about 45 percent of the "missing women" ?or, more specifically, for as many as 50 percent of the "missing women" in Egypt and West Asia; under 20 percent in Bangladesh, India, Pakistan and Nepal; and around 75 percent of the "missing women" in China.


'"/>

Source:University of Chicago Press Journals


Page: 1

Related biology news :

1. Scientists Replicate Hepatitis C Virus in Laboratory
2. Norovirus, AIDS vaccine and Hepatitis Virus
3. UCLA study assesses cost-effectiveness of Hepatitis B drugs
4. Natural Killers Could Lead to New Hepatitis Treatments
5. FDA Approves New Treatment for Chronic Hepatitis B
6. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
7. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
8. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
9. Hepatitis C complicated by morphine withdrawal
10. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
11. Hepatitis E takes a piggyback
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
Breaking Biology Technology: